VATTEMI, Gaetano Nicola
 Distribuzione geografica
Continente #
NA - Nord America 7.276
EU - Europa 4.933
AS - Asia 3.749
SA - Sud America 573
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 119
OC - Oceania 7
AN - Antartide 1
Totale 16.816
Nazione #
US - Stati Uniti d'America 7.054
RU - Federazione Russa 1.877
SG - Singapore 1.475
CN - Cina 1.092
GB - Regno Unito 916
BR - Brasile 476
IT - Italia 465
DE - Germania 354
VN - Vietnam 346
HK - Hong Kong 304
FR - Francia 272
SE - Svezia 262
FI - Finlandia 250
IE - Irlanda 204
KR - Corea 131
CA - Canada 118
UA - Ucraina 89
BD - Bangladesh 70
IN - India 61
TR - Turchia 60
NL - Olanda 51
MX - Messico 40
JP - Giappone 38
AR - Argentina 36
ID - Indonesia 35
PL - Polonia 33
BE - Belgio 29
NG - Nigeria 28
ES - Italia 27
ZA - Sudafrica 27
IQ - Iraq 22
PK - Pakistan 22
AT - Austria 19
IL - Israele 17
RO - Romania 15
LT - Lituania 14
CL - Cile 12
CH - Svizzera 11
CR - Costa Rica 11
EC - Ecuador 11
KE - Kenya 10
MA - Marocco 10
UZ - Uzbekistan 10
BJ - Benin 9
CO - Colombia 9
GT - Guatemala 9
MY - Malesia 9
VE - Venezuela 9
CW - ???statistics.table.value.countryCode.CW??? 8
TG - Togo 8
SV - El Salvador 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
KZ - Kazakistan 6
NI - Nicaragua 6
PH - Filippine 6
PR - Porto Rico 6
PY - Paraguay 6
AU - Australia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
SA - Arabia Saudita 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
JM - Giamaica 4
AM - Armenia 3
CG - Congo 3
DZ - Algeria 3
EE - Estonia 3
GP - Guadalupe 3
HN - Honduras 3
HR - Croazia 3
LB - Libano 3
NO - Norvegia 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
KG - Kirghizistan 2
LV - Lettonia 2
MT - Malta 2
MU - Mauritius 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 16.646
Città #
Dallas 987
Ashburn 805
Singapore 777
Southend 740
San Jose 687
Moscow 683
Chandler 553
Jacksonville 500
Woodbridge 380
Hong Kong 300
Verona 231
Beijing 222
Council Bluffs 204
Ann Arbor 203
Dublin 203
Houston 185
The Dalles 156
New York 144
Munich 141
Los Angeles 126
Ho Chi Minh City 112
Wilmington 84
Helsinki 82
Lawrence 82
Princeton 82
Santa Clara 80
Hanoi 78
Jinan 78
Shenyang 66
Nanjing 61
São Paulo 54
Columbus 43
Tianjin 39
Buffalo 37
Hebei 36
Orem 35
London 32
Milan 32
Toronto 32
Redondo Beach 31
Tokyo 30
Warsaw 29
Brussels 28
Seattle 28
Denver 27
Haikou 27
Phoenix 27
Turku 27
Amsterdam 26
Montreal 26
Seoul 26
Sindelfingen 26
Abuja 25
Boardman 25
Chicago 24
Chennai 22
Hangzhou 22
Jakarta 22
Johannesburg 22
Atlanta 21
Frankfurt am Main 21
Nanchang 21
Ningbo 21
Changsha 20
Guangzhou 20
Taizhou 20
Haiphong 19
Poplar 19
Taiyuan 19
Dearborn 18
Jiaxing 18
Nuremberg 18
Zhengzhou 18
Brooklyn 17
San Francisco 16
Lappeenranta 15
Norwalk 15
Da Nang 14
Mexico City 14
North Bergen 14
Rio de Janeiro 14
Washington 14
Charlotte 13
Fuzhou 13
Rome 13
Stockholm 13
Bologna 12
Las Vegas 12
Boston 11
Kent 11
Manchester 11
Redwood City 11
Vilnius 11
Nairobi 10
Redmond 10
Vienna 10
Belo Horizonte 9
Cotonou 9
Falkenstein 9
Lancaster 9
Totale 10.495
Nome #
A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates. 336
Abnormal expression of RNA polymerase II associated proteins in muscle of patients with myofibrillar myopathies. 285
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 267
Overexpression of TNF-α in mitochondrial diseases caused by mutations in mtDNA: evidence for signaling through its receptors on mitochondria. 261
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 257
Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia. 244
Bortezomib-induced muscle toxicity in multiple myeloma 240
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. 235
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 231
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 229
Autophagy, inflammation and innate immunity in inflammatory myopathies. 228
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 227
A novel de novo GFAP variant causes a juvenile-onset Alexander disease with bilateral vocal cord paralysis 220
BACE1 and BACE2 in pathologic and normal human muscle 220
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 220
A novel emerin gene mutation in Emery Dreifuss muscular dystrophy patient with spontaneous chordae tendinae rupture 215
Endothelial dysfunction and increased oxidative stress in mitochondrial diseases. 209
Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study. 207
McArdle disease and sporadic inclusion-body myositis. 206
Chronic graft-versus-host-disease-related polymyositis: a 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation 206
A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia 202
Selective pseudohypertrophy of vastus medialis muscles associated with calpain 3 deficiency. 201
Evidence for caspase-dependent programmed cell death along with repair processes in affected skeletal muscle fibres in patients with mitochondrial disorders 201
Adult-onset muscular dystrophy in a cat associated with a presumptive alteration in trafficking of caveolin-3. 200
Brody Disease: insights into biochemical features of SERCA1 and identification of a novel mutation. 196
Amyloid myopathy: an intriguing diagnosis 196
A novel in-frame deletion in MYOT causes an early adult onset distal myopathy 195
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 195
Endothelial dysfunction in mitochondrial diseases: biological and biochemical evidence of increased oxidative stress and peroxinitrite generation 195
Acute sarcomeric M-Line Disease associated with ATP synthase subunit α autoantibodies in ankylosing spondylitis 195
Autoantibody testing in patients with myositis: clinical accuracy of a multi parametric line immunoassay 193
Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. 190
Calpain 3 deficiency presenting as fiber type disproportion. 187
Programmed cell death occurs in muscle fibers with mitochondrial dysfunction 186
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. 186
Brody syndrome: A clinically heterogeneous entity distinct from Brody disease: A review of literature and a cross-sectional clinical study in 17 patients. 186
Non-hematologic toxicity of bortezomib in multiple myeloma: the neuromuscular and cardiovascular adverse effects 186
Polymyositis in solid organ transplant recipients receiving tacrolimus. 183
Muscular dystrophy with reduced beta-sarcoglycan in a cat. 182
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta 182
Characterization of sarcoplasmic reticulum Ca(2+) ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy 181
T-cell anti-apoptotic mechanisms in inflammatory myopathies 177
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 177
Immunoblot as a potential diagnostic tool for myofibrillar myopathies 177
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 175
Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patients 175
Human skeletal muscle as a target organ of trichloroethylene toxicity. 173
Evidence of ER stress and UPR activation in patients with Brody disease and Brody syndrome 173
Cutis verticis gyrata, mental retardation and Lennox-Gastaut syndrome: a case report 172
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1C. 172
The role of muscle biopsy in investigating isolated muscle pain 171
Multiple acyl-COA dehydrogenase deficiency in elderly carriers 166
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 164
Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mithocondrial diseases 163
Transthyretin Val122Ile, accumulated Aβ, and inclusion-body myositis aspects in cultured muscle 160
Expression of Protein Kinase C isoforms and interleukin-1beta in myofibrillar myopathy 160
Whole-exome sequencing in patients with protein aggregate myopathies reveals causative mutations associated with novel atypical phenotypes 159
Pearls & Oy-sters: An unusual case of varicella-zoster virus cerebellitis and vasculopathy. 158
SERCA1 and calsequestrin storage myopathy: a new surplus protein myopathy. 156
Acetylcholine receptor-antibody-positive myasthenia gravis presenting with early atrophy and nonfluctuating weakness of proximal limb muscles 155
Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles 154
Upper camptocormia in Parkinson's disease: Neurophysiological and imaging findings of both central and peripheral pathophysiological mechanisms 154
Sarcoidosis and inclusion body myositis. 153
Neuropathology of mitochondrial diseases 151
Reversible upper limb muscle weakness with selective loss of thick filaments 149
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. 148
Protein expression of canine and feline muscular dystrophies 148
Human mutated MYOT and CRYAB genes cause a myopathic phenotype in Zebrafish 146
Relapsing-remitting painful masses of the skeletal muscle 146
Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. 144
Persistent dystrophin protein restoration 90 days after a course of intraperitoneally administered naked 2'OMePS AON and ZM2 NP-AON complexes in mdx mice. 144
Expression of late myogenic differentiation markers in sarcoplasmic masses of patients with myotonic dystrophy 140
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 134
Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis 130
Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation 130
Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis 129
Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers 128
Neurogenic disease with high CK: think muscle 127
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 127
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa 126
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes 124
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: a simple test to identify this condition 123
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. 122
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 122
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. 121
Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy 121
Dermatomyositis and retroperitoneal germ cell cancer 118
Transcriptional behavior of DMD gene duplications in DMD/BMD males. 118
Physical training promotes remodeling of the skeletal muscle extracellular matrix: An ultrastructural study in a murine model of Down syndrome 104
Novel mitochondrial tRNA(Leu(CUN)) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 103
Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy 99
Sporadic inclusion body myositis at the crossroads between muscle degeneration, inflammation, and aging 98
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 87
Toll-like receptors and IL-7 as potential biomarkers for immune-mediated necrotizing myopathies 86
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies: Experience From the Italian Network 83
Evaluation of aggrephagy markers in myofibrillar myopathies 80
The FSHD jigsaw: are we placing the tiles in the right position? 76
Nucleolar FRG2 lncRNAs inhibit rRNA transcription and cytoplasmic translation, linking FSHD to dysregulation of muscle-specific protein synthesis 71
Case Report: Simultaneous presentation of end-stage heart failure with cardiogenic shock requiring emergency transplantation in monozygotic twins with myofibrillar myopathy: a previously unknown genetic disease? 59
Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients 48
Totale 16.715
Categoria #
all - tutte 56.029
article - articoli 54.843
book - libri 0
conference - conferenze 1.186
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022305 0 0 0 0 18 13 8 38 17 12 48 151
2022/20231.474 113 166 143 233 154 329 14 89 177 11 23 22
2023/2024724 29 74 54 73 77 134 27 70 10 44 83 49
2024/20252.324 104 108 80 340 129 112 197 146 366 133 183 426
2025/20267.182 418 692 587 1.103 1.714 427 661 321 570 384 109 196
2026/20271.239 65 149 188 747 90 0 0 0 0 0 0 0
Totale 16.816